The vascular endothelium offers an attractive model for detecting functional abnormalities prior to structural changes in the vasculature. Demonstration of progression from endothelial dysfunction through to atherosclerosis is required. Measurements of forearm bloodflow, biochemical markers and biophysical assessments of the endothelium have been employed as research tools for investigating pre-symptomatic atherosclerosis.
However, studies examining endothelial function in type 1 diabetes have been sparse and conflicting. Differences in methodology and the study populations were potential confounding factors. Augmented vasodilatory prostanoids compensate for reduced nitric oxide bioavailability in determining endothelial function in type 1 diabetes. Hyperglycaemia appears to be the initiating event in type 1 diabetes which promotes a variety of biochemical events which are pathogenic to the endothelium.
Improved understanding of the endothelium may facilitate the development of novel diagnostic tools and interventions targeting the accelerated atherosclerosis associated with type 1 diabetes.
Krolewski AS , Kosinski EJ, Warram JH et al. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol1987;59:750-5.
2.
Kannel WB, Kannel C., Paffenberger RS Jr et al. Heart rate and cardiovascular mortality: the Framingham Study . Am Heart J1987;13:1489-99.
3.
Moorish NJ, Stevens LK, Fuller JH et al. Risk factors for macrovascular disease in diabetes mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease in Diabetics. Diabetologia1991;34:590-4.
4.
Peppa-Patrikou M., Scordili M., Antoniou A. et al. Carotid atherosclerosis in adolescents with IDDM. Relation to urinary endothelin, albumin, free cortisol, and other factors. Diabetes Care1998;21:1004-07.
5.
Hadock S., Richardson M., Winocour PH et al. Intimal alterations in rabbit aortas during the first 6 months of alloxan-induced diabetes. Arterioscler Thromb Vasc Biol1991;11:517-29.
6.
Ross R.The pathogenesis of atherosclerosis; a perspective for the 1990's . Nature1993;362:801-09.
7.
Calermajer DS , Sorensen KE, Gooch VM et al. Non-invasive detection of endothelial function in children and adults at risk of atherosclerosis . Lancet1992;340:1111-15.
8.
Behrendt D., Ganz P.Endothelial function. From vascular biology to clinical applications. Am J Cardiol2002;90(10C):L40-8.
9.
Storey AM, Perry CJ, Petrie JREndothelial dysfunction in type 2 diabetes. Br J Diabetes Vasc Dis2001;1:22-7.
10.
Moncada S., Radomski MW, Palmer RMJ.Endothelium-derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol1988;37:2495-501.
11.
Crea F., Biasucci LM, Buffon A. et al. Role of inflammation in the pathogenesis of unstable coronary artery disease. Am J Cardiol1997;80:10-16E.
Diodati JG, Dakak N., Gilligan DM et al. Effect of atherosclerosis on endothelium-dependent inhibition of platelet activation in humans. Circulation1998;98:17-24.
14.
Stehouwer CD , Lambert J., Donker AJ et al. Endothelial dysfunction and pathogenesis of diabetic angiopathy . Cardiovasc Res1997 ;34:55-68.
15.
Pieper GMEnhanced, unaltered and impaired nitric oxide mediated endothelium dependent relaxation in experimental diabetes mellitus: importance of disease duration . Diabetologia1999;42:204-13.
16.
Benjamin N., Calver A., Collier J. et al. Measuring forearm bloodflow and interpreting the responses to drugs and mediators. Hypertension1995; 25:918-23.
17.
Ludmer PL, Selwyn AP, Shook TI et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med1986;315:1046-51.
18.
Takase B., Akima T., Uehata A. et al. Close relation between endothelium-dependent flow mediated vasodilation in coronary and brachial artery in human. J Am Coll Cardiol1998;31:359A.
19.
Clarkson P. , Celermajer DS, Donald AE et al. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol1996 ;28:573-9.
20.
Schroeder S. , Enderle MD, Ossen R. et al. Noninvasive determination of endothelium-mediated vasodilation as a screening test for coronary artery disease: Pilot study to assess the predictive value in comparison with angina pectoris, exercise electrocardiography, and myocardial perfusion imaging. Am Heart J1999;138:731-9.
21.
Drexler H., Zeiher AMProgression of coronary endothelial dysfunction in men and its potential clinical significance. Basic Res Cardiol1991 ;86: 223-32.
22.
Chowienczyk PJ, Cockcroft JR, Ritter JMDifferential inhibition by NGmonomethyl-L-arginine of vasodilator effects of acetylcholine and methacholine in human forearm vasculature. Br J Pharmacol1993;110: 736-8.
23.
Chowienczyk PJ, Cockcroft JR, Ritter JMBlood flow responses to intraarterial acetylcholine in man: effects of basal flow and conduit vessel length. Clin Sci1994;87:45-51.
24.
Rossi M., Lall K., Standfield N., Dornhurst A.Impaired vasoconstriction of peripheral cutaneous blood flow in type 1 diabetic patients following food ingestion. Diabetic Med1998;15:463-6.
25.
Pitkanen OP , Nuutila P., Raitakari OT et al. Coronary Flow reserve is reduced in young men with IDDM. Diabetes1998;47:248-54.
26.
Lehmann ED, Hopkins KD, Rawesh A. et al. Relation between number of cardiovascular risk factors/events and noninvasive Doppler ultrasound assessments of aortic compliance. Hypertension1998;32:565-9.
27.
Nicolaides E., Jones CJH.Type 2 diabetes - implications for macrovascular mechanics and disease. Br J Diabetes Vasc Dis2002;2:9-12.
28.
Brooks B., Molyneaux L., Yue DKAugmentation of central arterial pressure in type 1 diabetes. Diabetes Care1999;22:1722-7.
29.
Westerbacka J., Uosukainen A., Makimattila S. et al. Insulin-induced decrease in large artery stiffness is impaired in uncomplicated type 1 diabetes mellitus. Hypertension2000;35:1043-8.
30.
van Veen S. , Chang PCProstaglandin and nitric oxide mediate insulin-induced vasodilation in the human forearm. Cardiovasc Res1997;34: 223-9.
31.
Bots ML, Hoes AW, Hoffman A. et al. Cross-sectionally assessed carotid intima-media thickness relates to long-term risk of stroke, coronary heart disease and death as estimated by available risk functions. J Intern Med1999;245:269-76.
32.
McVeigh GF, Hamilton PK, Morgan DREvaluation of mechanical arterial properties: clinical, experimental and therapeutic aspects. Clin Sci2002;102:51-67.
33.
Zureik M., Ducimetiere P., Touboul PJ et al. Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol2000;20:1622-9.
34.
Balbarini A. , Buttitta F., Limbruno U. et al. Usefulness of carotid intima-media thickness measurement and peripheral B-mode ultrasound scan in the clinical screening of patients with coronary artery disease. Angiology2000;51:269-70.
35.
Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group . Diabetes1999;48:383-90.
36.
Huvers FC, De Leeuw PW, Alfons JHM et al. Endothelium-dependent vasodilation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycaemic conditions. Diabetes1999 ;47:1300-07.
37.
Elhadd TA, Kennedy G., Hill A. et al. Abnormal markers of endothelial cell activation and oxidative stress in children, adolescents and young adults with type 1 diabetes with no clinical evidence of vascular disease. Diabetes Metab Res Rev1999;15:405-11.
38.
Hofmann MA, Kohl B., Zumbach MS et al. Hyperhomocysteinaemia and endothelial dysfunction in IDDM. Diabetes Care1998;21:841-8.
39.
Usui M., Matsuoka H., Miyazaki H., Ueda S., Okuda S., Imaizumi T.Endothelial dysfunction by acute hyperhomocysteinaemia: restoration by folic acid. Clin Sci1999;96:235-9.
40.
Poston L., Taylor PDEndothelium-mediated vascular function in insulin-dependent diabetes mellitus . Clin Sci1995;88:245-55.
41.
Chan NN, Vallance P., Colhoun HMNitric oxide and vascular responses in type 1 diabetes. Diabetologia2000;43:137-47.
42.
Johnstone MT , Creager SJ, Scales KM et al. Impaired endothelium-dependent vasodilatation in patients with insulin-dependent diabetes mellitus. Circulation1993;88:2510-16.
43.
Williams SB , Goldfine AB, Timimi FK et al. Acute hyperglycaemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation1998;97:1695-701.
44.
Akbari CM, Saouaf R., Barnhill DF et al. Endothelium-dependent vasodilation is impaired in both microcirculation and macrocirculation during acute hyperglycaemia. J Vasc Surg1998;28:687-94.
45.
Macklin AV, Viberti GC, Ritter J.Forearm blood flow in type 1 diabetics during systemic hyperglycemia . Diabetologia1998;41:A310.
46.
Avogadro A. , Calo L., Piarulli F. et al. Effect of acute ketosis on the endothelial function of type 1 diabetic patients: The role of nitric oxide. Diabetes1999;48:391-7.
47.
Wang W., Diamond SLDoes elevated nitric oxide production enhance the release of prostacyclin from shear stressed aortic endothelial cells. Biochem Biophys Res Commun1997;233:748-51.
48.
Cardillo C. , Nambi SS, Kilcoyne CM et al. Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation1999; 100:820-5.
49.
Dogra G., Rich L., Stanton K. et al. Endothelium-dependent and independent vasodilation studies at normoglycaemia in type 1 diabetes with and without microalbuminuria. Diabetologia2001;44:593-601.
50.
Stuhlinger MC, Tsao PS, Her JH et al. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine . Circulation2001;104:2569-75.
51.
O'Byrne SO, Forte P., Roberts J. et al. Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion . Diabetes2000;49:857-62.
52.
Meeking DR, Browne DL, Allard S. et al. Effects of cyclo-oxygenase inhibition on vasodilatory response to acetylcholine in patients with type 1 diabetes and nondiabetic subjects . Diabetes Care2000;23:1840-3.
53.
Browne DL, Allard SE, Munday LJ et al. The relative contributions and synergy between vasodilatory prostanoids and nitric oxide in determining endothelial function in type 1 diabetes. Diabetes2001;50(suppl 2):A599.
54.
Tesfamariam B., Jakubowski JA, Cohen RAContraction of diabetic rabbit aorta caused by endothelium-derived PGH2-TxA2. Am J Physiol1989;257:H1327-33.
55.
Tesfamariam B., Brown ML, Deykin D., Cohen RAElevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest1990;85:929-32.
56.
Katusic ZS, Schugel J., Consentino F. et al. Endothelium dependent contractions to oxygen-derived free radicals in the canine basilar artery. Am J Physiol1993;264:H859-64.
57.
Thorne S., Mullen MJ, Clarkson P. et al. Early endothelial dysfunction in adults at risk from atherosclerosis: different responses to L-arginine. J Am Coll Cardiol1998;32:110-16.
58.
Schade DS, Eaton RP, Freidman N. et al. The intravenous, intraperitoneal and subcutaneous routes of insulin delivery in diabetic man. Diabetes1979;28:1069-72.
59.
Wolf BA, Williamson JR, Eason RA et al. Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J Clin Invest1991;87:31-8.
60.
Hawthorne GC , Bartlett K., Hetherington CS et al. The effect of high glucose on polyol pathway activity and myoinositol metabolism in cultured human endothelial cells. Diabetologia1989;32:196-9.
61.
Tesfamariam B. , Palacino JJ, Weisbrod RM et al. Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aorta. J Cardiovasc Pharmacol1993;21:205-11.
62.
Bucula R., Tracey KJ, Cerami A.Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J Clin Invest1991;87:432-8.
63.
Watts GF, Playford DADyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesis. Atherosclerosis1998;141:17-30.
64.
Kugiyama K. , Kerns SA, Morriset JD et al. Impairment of endothelium-dependent relaxation by lysolecithin in modified low density lipoproteinNature1990;344:160-2.
65.
Laakso M., Edelmann SV, Bretchel G. et al. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes1992;41: 1076-83.
66.
Skyrme-Jones RAP , Berry KL, O'Brien RC et al. Basal and exercise-induced skeletal muscle blood flow is augmented in type 1 diabetes mellitus. Clin Sci2000;98:111-20.
67.
Tooke JEMicrovascular haemodynamics in diabetes mellitus. Clin Sci1986;70:119-25.
68.
Parving HH, Viberti GC, Keen H. et al. Haemodynamic factors in the genesis of diabetic microangiopathy . Metabolism1983;32:943-9.
Taddei S., Galetta F., Virdis A. et al. Physical activity prevents age related impairment in nitric oxide availability in elderly athletes. Circulation2000; 101:2896-901.
71.
Pieper GMEnhanced, unaltered and impaired nitric oxide mediated endothelium dependent relaxation in experimental diabetes mellitus: importance of disease duration . Diabetologia1999;42:204-13.
